| 发明名称 |
COMPOSITIONS INCLUDING CABAZITAXEL |
| 摘要 |
Provided herein are pharmaceutical compositions including cabazitaxel and parenteral formulations including cabazitaxel. The compositions and parenteral formulations are useful in methods for treating prostate cancer including administering the parenteral formulations prepared with the compositions described herein. |
| 申请公布号 |
US2016120742(A1) |
申请公布日期 |
2016.05.05 |
| 申请号 |
US201414532703 |
申请日期 |
2014.11.04 |
| 申请人 |
Sandoz AG |
发明人 |
Wickramanayake Priyanga |
| 分类号 |
A61J1/00;A61K45/06;A61K47/10;A61K47/12;A61K31/337;A61K47/26 |
主分类号 |
A61J1/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical composition comprising:
a) from 0.5 to 1.5 weight-% of cabazitaxel; b) from 20 to 40 weight-% of a polysorbate; c) from 15 to 22 weight-% of a C2-C4 alcohol; d) from 0.3 to 0.6 weight-% of an organic acid; e) from 40 to 60 weight-% of a polyethylene glycol; and f) from 0 to 5 weight-% of water; in each case based on the total weight of the composition. |
| 地址 |
Basel CH |
